Top 5 obstetric studies from September 2019

Technology may be used in ultrasounds, fetal heart rate interpretation, and prediction of adverse clinical outcomes.

In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.

At the 2023 Pediatric Academic Societies meeting, held in Washington, DC, from April 27 to May 1, 2023, the impact that air pollution and climate change has on infants was discussed.

Halley Crissman, MD, MPH, and Daphna Stroumsa, MD, MPH, MSC, discuss ways in which ob/gyns can provide high-quality care for transgender and nonbinary people assigned female sex at birth.

In a recent study, changes in gestational age distribution in the United States reflected increasing induction of labor rates between 1990 and 2017.

Following voluntary market withdrawal from Covis Pharma, the FDA has decided to withdraw the approval of Makena and its generics for reducing the risk of preterm birth.